Pountos Ippokratis, Corscadden Diane, Emery Paul, Giannoudis Peter V
Academic Department of Trauma & Orthopaedics, School of Medicine University of Leeds, UK.
Injury. 2007 Sep;38 Suppl 4:S23-33. doi: 10.1016/s0020-1383(08)70006-8.
Mesenchymal stem cells (MSCs) are undifferentiated multipotent cells which reside in various human tissues and have the potential to differentiate into osteoblasts, chondrocytes, adipocytes, fibroblasts and other tissues of mesenchymal origin. In the human body they could be regarded as readily available reservoirs of reparative cells capable to mobilize, proliferate and differentiate to the appropriate cell type in response to certain signals. These properties have triggered a variety of MSC-based therapies for pathologies including nonunions, osteogenesis imperfecta, cartilage damage and myocardial infarction. The outcome of these approaches is influenced by the methodologies and materials used during the cycle from the isolation of MSCs to their re-implantation. This review article focuses on the pathways that are followed from the isolation of MSCs, expansion and implantation.
间充质干细胞(MSCs)是未分化的多能细胞,存在于人体各种组织中,具有分化为成骨细胞、软骨细胞、脂肪细胞、成纤维细胞和其他间充质来源组织的潜力。在人体中,它们可被视为随时可用的修复细胞库,能够响应特定信号而动员、增殖并分化为适当的细胞类型。这些特性引发了多种基于间充质干细胞的治疗方法,用于治疗包括骨不连、成骨不全、软骨损伤和心肌梗死在内的病症。这些方法的结果受到从间充质干细胞分离到重新植入整个周期中所使用的方法和材料的影响。本文综述重点关注间充质干细胞从分离、扩增到植入所遵循的途径。